The global burden of cardiovascular disease
- PMID: 21762852
- DOI: 10.1016/S1474-5151(11)00111-3
The global burden of cardiovascular disease
Abstract
Cardiovascular disease (CVD) today is responsible for approximately one-third of deaths worldwide, and that figure will surely increase in both developing and developed countries as risk factors for the disease--primarily dyslipidemia, hypertension, obesity, diabetes, physical inactivity, poor diet, and smoking--continue to increase. Although these risk factors are modifiable, to date there is a relative paucity of measures to prevent or control them, particularly in developing countries. A population strategy combined with a high-risk strategy for CVD prevention could greatly reduce the burden of disease in the coming decades. Many initiatives are working, but many more are needed. This chapter provides background on the global burden of CVD and provides the context for the subsequent chapters addressing nurses' roles in reversing the bleak predictions for the ravages of CVD if risk factors are left unchecked in the coming decades.
Copyright © 2011 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
Similar articles
-
The global burden of cardiovascular disease.J Cardiovasc Nurs. 2011 Jul-Aug;26(4 Suppl):S5-14. doi: 10.1097/JCN.0b013e318213efcf. J Cardiovasc Nurs. 2011. PMID: 21659814
-
Estimates of global and regional premature cardiovascular mortality in 2025.Circulation. 2015 Sep 29;132(13):1270-82. doi: 10.1161/CIRCULATIONAHA.115.016021. Circulation. 2015. PMID: 26408271
-
Risk factors for cardiovascular disease in Canada.Can J Cardiol. 2003 Oct;19(11):1249-59. Can J Cardiol. 2003. PMID: 14571310
-
Reducing the global burden of cardiovascular disease: the role of risk factors.Prev Cardiol. 2002 Fall;5(4):188-99. doi: 10.1111/j.1520-037x.2002.00564.x. Prev Cardiol. 2002. PMID: 12417828 Review.
-
Novel therapeutic concepts: the epidemic of cardiovascular disease in the developing world: global implications.Eur Heart J. 2010 Mar;31(6):642-8. doi: 10.1093/eurheartj/ehq030. Epub 2010 Feb 22. Eur Heart J. 2010. PMID: 20176800 Review.
Cited by
-
Inhibition of in-stent restenosis after graphene oxide double-layer drug coating with good biocompatibility.Regen Biomater. 2019 Oct;6(5):299-309. doi: 10.1093/rb/rbz010. Epub 2019 Mar 19. Regen Biomater. 2019. PMID: 31616567 Free PMC article.
-
Dyslipidemia and its associated factors among adult cardiac patients at Ambo university referral hospital, Oromia region, west Ethiopia.BMC Cardiovasc Disord. 2023 Jun 24;23(1):321. doi: 10.1186/s12872-023-03348-y. BMC Cardiovasc Disord. 2023. PMID: 37355585 Free PMC article.
-
Investigating the Interplay of Toxic Metals and Essential Elements in Cardiovascular Disease.J Xenobiot. 2025 May 9;15(3):68. doi: 10.3390/jox15030068. J Xenobiot. 2025. PMID: 40407532 Free PMC article.
-
Estimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study.Sci Rep. 2021 Apr 27;11(1):9121. doi: 10.1038/s41598-021-88587-9. Sci Rep. 2021. PMID: 33907272 Free PMC article.
-
Investigation of Cardiovascular Health and Risk Factors Among the Diverse and Contemporary Population in London (the TOGETHER Study): Protocol for Linking Longitudinal Medical Records.JMIR Res Protoc. 2020 Oct 2;9(10):e17548. doi: 10.2196/17548. JMIR Res Protoc. 2020. PMID: 33006568 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical